Latham secures Patent Trial and Appeal Board victory for Corcept Therapeutics.
Michelle Ernst is a patent litigator and trial lawyer who represents brand-name pharmaceutical companies in district court (especially Hatch-Waxman) trials, Federal Circuit appeals, and before the United States Patent and Trademark Office.
Ms. Ernst advises companies in the life sciences, pharmaceutical, biotechnology, and healthcare industries on a full spectrum of patent and intellectual property matters, including diligence, portfolio development, and pre-suit investigation, in addition to litigation, trial, and appeal.
Ms. Ernst has a degree in Genetics and Molecular and Cell Biology (summa cum laude), was a cancer cytogeneticist prior to and during law school, and conducted cancer research as a Fulbright scholar in Singapore.
She leverages her scientific expertise and a comprehensive understanding of the pharmaceutical and biotechnology industries to help clients navigate the full litigation cycle. Ms. Ernst forges trusted relationships to craft litigation and commercial strategies that are responsive to the sophisticated science that drives her clients’ innovative businesses.
Ms. Ernst is a member of various professional organizations for women practitioners in the patent and intellectual property space, including ChIPs (Chiefs in Intellectual Property) and WIN (the Women in IP Network.
She also maintains an active pro bono practice and has worked on veterans’ rights and asylum matters.